破裂性动静脉畸形分级量表(RAGS)在多中心成人队列中的外部验证
本研究在五个神经外科中心回顾性纳入2012至2019年间首次急性脑动静脉畸形破裂的61例成人患者,比较RAGS与其他多种分级量表对三个随访时段分类与二分类改良Rankin量表(mRS)变化的预测价值,发现RAGS在所有随访时段均优于其他量表,结论认为RAGS是预测成人bAVM破裂后临床结局的可靠量表,并在治疗偏好不同的医疗中心间具有泛化性。
要点
- RAGS在全部随访时段预测分类mRS的AUROC分别为0.78、0.74、0.71,均优于其他量表。
- RAGS预测二分类mRS的AUROC分别为0.79、0.76、0.73,对应前6个月、6至12个月及12个月以后。
- 作者结论认为RAGS是预测成人bAVM破裂后临床结局的可靠量表,并在不同治疗偏好的中心间具有泛化性。
核心结论
- RAGS是预测成人脑动静脉畸形(bAVM)破裂后临床结局的可靠量表。
- RAGS在不同治疗偏好的医疗中心间证明了其泛化性。
研究设计与样本
- 在五个神经外科中心开展回顾性分析,提取2012年至2019年间首次急性bAVM破裂的患者。
- 共纳入61例患者,平均年龄43.6岁。
- 采用标准逻辑回归和受试者工作特征曲线下面积(AUROC)计算评估各量表的预测价值。
- 评估的量表包括:脑出血(ICH)、AVM相关ICH(AVICH)、Spetzler-Martin(SM)、补充SM(Supp-SM)、Hunt and Hess(HH)、格拉斯哥昏迷量表(GCS)、世界神经外科医师联盟(WFNS)和RAGS。
- 预测结局为三个随访时段(6个月以内、6个月至1年、1年以上)分类与二分类改良Rankin量表(mRS)的变化。
主要发现
- RAGS在所有随访时段均优于其他分级量表。
- 应用分类mRS时,RAGS在第一个6个月、6至12个月及12个月以后的AUROC分别为0.78、0.74和0.71。
- 应用二分类mRS时,对应上述三个时段的AUROC分别为0.79、0.76和0.73。
关键数值与推荐
- RAGS预测分类mRS:前6个月AUROC 0.78,6至12个月AUROC 0.74,12个月以后AUROC 0.71。
- RAGS预测二分类mRS:前6个月AUROC 0.79,6至12个月AUROC 0.76,12个月以后AUROC 0.73。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: While Ruptured Arteriovenous Malformation Grading Scale (RAGS) has recently been validated in children, the literature lacks validation on adults exclusively. Therefore, we aimed to determine the validity of RAGS on the external multicenter adult cohort and compare its accuracy with other scales. METHODS: A retrospective analysis was performed in five neurosurgical departments to extract patients who presented with the first episode of acute brain arteriovenous malformation (bAVM) rupture between 2012 and 2019. Standard logistic regression and area under the receiver operating curve (AUROC) calculations were performed to determine the value of the following scales: intracerebral hemorrhage (ICH), AVM-associated ICH (AVICH), Spetzler-Martin (SM), Supplemented SM (Supp-SM), Hunt and Hess (HH), Glasgow Coma Scale (GCS), World Federation of Neurological Surgeons (WFNS), and RAGS to predict change in categorical and dichotomized modified Rankin Scale (mRS) across three follow-up periods: within the 6 months, 6 months to 1 year, and above 1 year. RESULTS: Sixty-one individuals with a mean age of 43.6 years were included. The RAGS outperformed other grading scales during all follow-up time frames. It showed AUROC of 0.78, 0.74, and 0.71 at the first 6 months, between 6 and 12 months, and after 12 months of follow-up, respectively, when categorized mRS was applied, while corresponding values were 0.79, 0.76, and 0.73 for dichotomized mRS, respectively. CONCLUSION: The RAGS constitutes a reliable scale predicting clinical outcomes following bAVM rupture among adults. Furthermore, the RAGS proved its generalizability across medical centers with varying treatment preferences.
引用
- Antkowiak L, Rogalska M, Stogowski P, et al. External validation of the Ruptured Arteriovenous Malformation Grading Scale (RAGS) in a multicenter adult cohort. Acta Neurochir (Wien). 2022. PMID: 36473981. doi:10.1007/s00701-022-05433-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。